Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study ; volume:21 ; number:1 ; day:21 ; month:3 ; year:2021 ; pages:1-9 ; date:12.2021
BMC gastroenterology ; 21, Heft 1 (21.3.2021), 1-9, 12.2021
- Creator
-
Zhang, Jinhua
Li, Kangli
Pan, Lingling
Teng, Fei
Zhang, Peizhen
Lin, Bingquan
Yuan, Youwen
Wei, Xueyun
Li, Wenyuan
Zhang, Huijie
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12876-021-01721-9
- URN
-
urn:nbn:de:101:1-2021050617590247769341
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Jinhua
- Li, Kangli
- Pan, Lingling
- Teng, Fei
- Zhang, Peizhen
- Lin, Bingquan
- Yuan, Youwen
- Wei, Xueyun
- Li, Wenyuan
- Zhang, Huijie
- SpringerLink (Online service)
Other Objects (12)
Thyroid dysfunction in obese adults in relation to nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease
Genetically determined circulating micronutrients and the risk of nonalcoholic fatty liver disease
Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease
Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children
Author Correction: Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
Artificial intelligence in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Thyroid dysfunction in obese adults in relation to nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease
Genetically determined circulating micronutrients and the risk of nonalcoholic fatty liver disease
Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease
Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children
Author Correction: Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
Artificial intelligence in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Thyroid dysfunction in obese adults in relation to nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease
Genetically determined circulating micronutrients and the risk of nonalcoholic fatty liver disease
Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease
Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children
Author Correction: Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
Artificial intelligence in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Hepatic Innervations and Nonalcoholic Fatty Liver Disease